7Baggers
 hookipa pharma (nasdaq:hook) stock price up 2.6% – time to buy?  Defense World Sat, 08 Nov 2025 10:06:16 GMT
 Gilead Sciences (GILD) Acquires Key Assets from HOOKIPA Pharma  GuruFocus Fri, 31 Oct 2025 07:00:00 GMT
 Hookipa Pharma completes sale of HBV, HIV assets to Gilead  TipRanks Fri, 31 Oct 2025 07:00:00 GMT
 Hookipa Pharma Completes Sales of HBV and HIV Assets to Gilead Sciences  MarketScreener Fri, 31 Oct 2025 07:00:00 GMT

HOOKIPA Pharma Inc
(NASDAQ:HOOK) 

HOOK stock logo

HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II cli...

Founded: 2011
Full Time Employees: 85
CEO: Jörn Aldag  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends